Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Esophageal Neoplasms × Proton Therapy × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Meningioma 1 Esophageal Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1 Chondrosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cisplatin 28 Fluorouracil 21 Paclitaxel 19 Radiotherapy 16 Docetaxel 10 Radiation 7 Esophagectomy 7 Neoadjuvant Therapy 6 Irinotecan 6 Carboplatin 6 Oxaliplatin 5 Leucovorin 5 Capecitabine 5 sintilimab 4 pembrolizumab 4 camrelizumab 4 TP protocol 4 Surgical Procedures, Operative 4 Drug Therapy 4 Chemotherapy, Adjuvant 4 Trastuzumab 3 Immunotherapy 3 Chemoradiotherapy 3 tislelizumab 2 nimotuzumab 2 S 1 (combination) 2 Radiotherapy, Adjuvant 2 Platinum Compounds 2 Nivolumab 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05055648 2024-12-17

PROTECT

University of Aarhus

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡